2006 (All bulletins from '06 are in PDF format )

April: Hemoglobin A1C
April: Test Menu Updates
February: Specific Protein Method Change
February: Carbohydrate Antigen 19-9
February: Test Method Changes

2005 (All bulletins from '05 are in PDF format )

July: CEDIA Cyclosporine Plus Assay
June: Expanded Coagulation Reportable Range
May: Ova and Parasite Extermination
May: Bacterial Antigen Testing
May: Parathyroid Hormone
May: Homocysteine
February: Throat Cultures
February: Pediatric Referrence Intervals 2005
March: Technical Updates 2005
March: Cyclosporin

2004 (All bulletins from '04 are in PDF format )

November: FSH - SST Tubes
October: Staph Aureus
October: NCD Update
September: Chlamydia/GC
August: Flow Cytometry
July: National Coverage Decision Changes
June: Pediatric Reference Intervals 2004
May: CK-MB Test
April: Direct LDL Cholesterol
April: Troponin T
April: Cancer Antigen 15-3
April:Test Menu Additions: hs-CRP and Homocysteine
March: NT-proBNP Implementation
February: Alert Value Policy Revisioin
January: Testosterone Total Reference Range Update
January: Le Cell Test
January: Electrophoresis Range Change

2003 (All bulletins from '03 are in PDF format )

December: Specimen Requirement Update
October: Hormone Reference Range Changes
October: Parathyroid Hormone, Intact Reference Range Change
September: National Coverage Decisions Update
August: Hematology References Ranges
August: APTUS References Ranges
July: White Blood Cells Reference Range
July: Pathology Report Bulletin
July: Prothrombin Time Normal Ranges
July: Annual notice to physicians
April 2003 Specimen Requirements Update
March 2003 National Coverage Decision (NCD) Changes
February 2003 Changes in Chemistry Tests

2002

December 2002 Prothrombin Time Results Change
November 2002 NEW ICD-9 Information
November 2002: Pathology Services
July 2002: Annual Notice to Physicians
July 2002: Insurance Bulletin
June 2002: Ova and Parasite Examination Procedure Changes
June 2002: NIDA/DOT Drug Screens
June 2002: Anaerobic Susceptibility Changes
June 2002: Advance Beneficiary Notes
May 2002 Revised DRL Requisition
April 2002 Occult Blood
March 2002 Expanded Coverage for Tacrolimus
March 2002 Four Marker Screen For Fetal Abnormalities
February 2002 Meningitis Screen Criteria
February 2002 Cytomegalovirus lgG Test
February 2002 Ammonia Specimen Requirements
February 2002 Insurance Update

2001

December 2001 Limited Coverage Tests Update
December 2001 Hemoglobin A1C Reference Range
November 2001 Coagulation Reference Ranges
September 2001 Limited Coverage Test Update
September 2001 Safety Needle Devices
August 2001 Lipid Reference Ranges
August 2001 Microalbumin, Shiga Toxin - Producing E. Coli, Double Stranded DNA, Cardiolipin Antibodies, Varicella Zoster lgG
July 2001 Mayo Medical Laboratories
June 2001 Limited Coverage Tests Update 9
May 2001 Immunology Reference Ranges
May 2001 Free T3 and Free T4
March 2001 Notice of Expanded Coverage
March 2001 Customer Satisfaction Survey
March 2001 TSH - Ultra Sensitive
February 2001 CPT Code Update, Limited Coverage Update
January 2001 Potassium (K) Reference Range

2000

December 2000 PSA Screen
November 2000 Schilling Test
October 2000 CD4 - CD8 Counts
October 2000 Lyme Disease lgGligm
October 2000 Limited Coverage Manual
August 2000 Mycoplasma lgG
August 2000 Anti-Neutrophil Cytoplasmic Antibodies (ANCA)
July 2000 Ammonia Reference Range
June 2000 Clostridium Difficile Toxins
May 2000 Tacrolimus
May 2000 Prothrombine Time (PT) Specimen Requirements
April 2000 D-Dimer
April 2000 Cyclosporin
April 2000 Reticulocyte Counts
April 2000 Increased Potassium Results
March 2000 CPT Codes Update
March 2000 Progesterone Reference Ranges
March 2000 Susceptibility Testing
February 2000 Ferritin Reference Ranges
January 2000 Critical Results Policy